Clinical trial · Interventional
Feasibility and Patient Reported Tolerance of Cryotherapy With the Cooral ® Mouth Cooling Device [MCD) in Patients Undergoing Radiation Therapy
Pilot Trial for Feasibility and Patient Reported Tolerance of Cryo-therapy With the Cooral ® Mouth Cooling Device [MCD) in Patients Undergoing Radiation Therapy for Head and Neck Malignancies
NCT04915599CI-TRIAL-00058833CooRaycompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is to investigate the use of the Cooral ® standardized CyT device to achieve a constant and reproducible cooling of the oral mucosa to prevent OM in patients undergoing RT in the head and neck region.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oral Mucositis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cooral® mouth cooling device (MCD) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Intervention group
- description
- Patients are assigned to using the Cooral® MCD after radiotherapy for 60 min. along with general oral care (GOC). The MCD will be placed into the subjects' mouth and remain intraorally for 60 minutes. After each fraction, i.e. session of RT, the subjects insert the MCD inside their mouth and can start the Cooral ® thermostat system themselves when they feel comfortable. The stopwatch will be started by the patient as soon as thermostat is running. The patient is asked to write down the starting and the stopping time of the 60-minute procedure. Thereafter the subject will receive a questionnaire to record the tolerance for the device. Patients will be also informed about standard of care (SOC) that should be regularly performed.
- interventionNames
- Device: Cooral® mouth cooling device (MCD)
Primary outcomes (1)
- measure
- Change in Feasability Questionnaire (regarding Patient reported tolerance of cryotherapy with Cooral ®)
- timeFrame
- up to 1 week (assessed in radiotherapy treatment period (0-10 days after baseline)
- description
- Change in Feasability Questionnaire (regarding Patient reported tolerance of cryotherapy with Cooral ®). On this questionnaire provided to the patients at each session, they are asked to enter the break intervals and to choose a reason for the interruption from a list or to enter another reason in a provided text field. On the form there are additional question regarding the comfort of handling and wearing the device on a four scale questionnaire (the lower the score, the better the comfort of handling and wearing the device).
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Karnofsky Performance Score (KPS) \>/= 60% * life expectancy \> 9 months * histologically proven malignant disease of the head and neck region * lntensity Modulated RadiationTherapy (IMRT) radiotherapy * Minimal Dose to the oral mucosa \>/= 30 Gy (EQD2 w. a/ß 2) * Simultaneous use of mouthwashes is allowed if previously prescribed by the treating physician Exclusion Criteria: * history of Severe oral Mucositis (SOM) due to chemotherapy within the last 3 months * previous radiotherapy in the head-neck region * previous cryotherapy within the last 6 weeks * Minimal doses \</=30 Gy (EQD2 w. a/ß 2) * known history of ethylene-vinyl acetate allergy * Simultaneous use of other forms of oral cryotherapy
References
Publications (0)
Data not yet available
No reference posted for this study.